New Zealand has no shortage of ideas. It has founders building software for global markets, exporters with trusted products, scientists working close to commercial opportunity, and a retirement savings system in the KiwiSaver system that has become a significant pool of domestic capital.

The harder question is whether enough of that capital is reaching the places where it can lift productivity, help companies scale and create durable economic value for founders, investors and the country itself.

For Scott Weenink, the issue is not simply whether more money exists in the system. It is whether New Zealand is directing enough long-term capital towards productive businesses, technology adoption and companies capable of growing beyond, what is very small on a global level, the domestic market. In a small economy, that distinction matters. Capital that merely chases familiar and/ or safe assets may preserve wealth for some owners, but capital that helps businesses invest, hire, innovate and expand with global ambition is what changes the national trajectory.

The productivity problem is also a capital problem

New Zealand’s productivity challenge is well documented. The Treasury’s 2025 analysis on innovation and capital argued that New Zealand has not experienced the same productivity growth as comparable countries, and that the country remains, despite the KiwiSaver system, relatively capital shallow. The OECD has made a similar point, noting that deeper and more competitive capital markets, along with foreign investment, are central to lifting productivity.

Those observations can sound technical, but the practical meaning is simple. Workers become more productive when they have better tools, better systems, better infrastructure and better technology around them. A business that cannot invest in those things is unlikely to create higher-wage, higher-skill jobs at scale. A country that underinvests in productive capacity should not be surprised when growth feels harder than it ought to.

The debate is often framed as a policy question, and policy clearly matters. Tax settings, regulation, immigration, infrastructure, energy costs, competition and foreign investment rules all shape the environment in which firms make decisions. But there is also a cultural and institutional question: does New Zealand reward the patient allocation of capital to productive enterprise with significant growth potential, or does it default too quickly to assets that feel safer because they are familiar?

Why patient capital matters

Patient capital is not passive capital. It is money that is prepared to stay with a good business through the stages of growth that rarely fit neatly into a short reporting cycle. It allows a company to invest before the payoff is obvious, to hire ahead of demand, to build technology, to enter new markets and to make decisions that are right over years rather than weeks.

That distinction matters in the view of Scott Weenink because many of the businesses New Zealand most needs will not be built on short horizons. Technology companies, financial services challengers, export platforms and specialist manufacturers often require years of reinvestment before their value is fully visible. If the capital behind them is impatient, the company can be forced into smaller ambitions than it or the country actually needs.

Punakaiki Fund, who I recently joined as Chair, is an example of “patient capital” with it being an evergreen venture capital fund that focusses on investing in early-stage technology companies in New Zealand. It has an outstanding track record of supporting New Zealand technology companies to reach their potential through patient investment and support- Quantifi Photonics, Timely and Vend being obvious examples. New Zealand needs more investors and investment vehicles like this.

The point is not that every company should be funded forever, or that investors should ignore risk. Quite the opposite. Patient capital works only when it is disciplined. It still asks hard questions about governance, margins, management, market size and execution. It still expects accountability. But it understands that building enduring value is different from extracting a quick return.

From savings to ownership

One reason this question is becoming more important is the growth of KiwiSaver. The Financial Markets Authority reported that total KiwiSaver funds under management reached $123 billion in the year to March 2025, after contributions of $12.2 billion and net investment returns of $6.4 billion. That is a material pool of long-term savings in a country that has historically leaned heavily towards property as the default wealth-building vehicle.

The existence of a larger savings pool does not automatically solve the productive capital challenge. A retirement savings system like KiwiSaver can help households build security, but it also raises a wider question about ownership. If more New Zealanders are indirect owners of productive assets through diversified funds, they have a stake in the businesses, markets and governance systems that shape long-term prosperity.

That does not mean turning savers into speculators. It means treating ownership of productive enterprise as a normal part of national wealth-building. It means understanding that a share in a well-run company is not a casino ticket but a claim on future earnings, employment, innovation and service. It also means being honest that capital markets need trust. People will not commit long-term savings to systems they do not understand or institutions they do not believe are acting fairly.

Governance is where capital earns confidence

Scott Weenink’s background sits across law, private investment, financial services, governance and sport. He is a former corporate finance lawyer, a New Zealand based investor and company director, Chair of Xceda Capital Group and Punakaiki Fund, and a founding shareholder and former Chair of Generate KiwiSaver. That mix of roles gives him a practical view of how capital, governance and trust interact.

Good governance matters because patient capital cannot simply rely on optimism. Investors need to know that boards understand risk, management is being challenged constructively, incentives make sense and long-term value is being protected. For a small market like New Zealand, this is particularly important. When capital is scarce, misallocation hurts more. When trust is damaged, it is harder to rebuild.

This is where the conversation about productivity connects to the conversation about boards. Capital is not productive because it has been raised. It becomes productive when it is allocated well, governed well and used to build something with a future. A business with patient investors but weak governance can still destroy value. A business with strong governance but insufficient growth capital can remain smaller than it should. The best outcomes require both.

The small-country advantage

New Zealand’s size is often treated as a constraint, but it can also be an advantage. Smaller markets can build trust quickly. Networks are tighter, reputations travel faster and capable people often operate across several sectors in a way that creates useful cross-pollination. A director who has be involved in a broad range of sectors, and a broad range of markets, may bring a broader lens than a career spent inside one narrow lane.

The risk is that small markets also become too comfortable. Familiarity can make capital conservative in the wrong way. It can lead investors towards the same assets, the same people and the same assumptions. It can make new sectors look riskier simply because they are less well understood. For Weenink, one of the tests for New Zealand is whether it can combine the prudence of a small country with the ambition of a country that knows it must, and can, compete globally.

That will require better bridges between savings, private capital, public markets and growing companies. It will also require more respect for the difficult middle stage of business building, after a company has proved an idea but before it has become obvious that it will be successful. That is often where good companies either become serious or quietly stall. It is also where patient capital can have the greatest effect.

A broader definition of national wealth

The national conversation about wealth still tilts heavily towards what people own personally: houses, deposits, retirement balances, investment portfolios. Those things matter. But a country also needs to ask what it is building collectively. Are there more export-capable companies? Are younger workers seeing careers with a future in New Zealand? Are domestic firms adopting technology quickly enough? Are boards taking the right risks for long-term value rather than simply defending what already exists?

These questions are not separate. A country with deeper productive investment tends to create more capable firms. More capable firms create better jobs, stronger tax bases, larger pools of expertise and more examples of success for the next generation to copy. The benefit of patient capital is therefore not only financial. It is institutional and cultural as well.

For Scott Weenink, New Zealand’s challenge is to become more deliberate about where ambition meets capital. The country does not need reckless risk-taking, and it does not need growth stories built on slogans. It needs disciplined investors, competent boards and leaders willing to build beyond the limits of the local market. If more capital moves towards productive enterprise, and if that capital is matched by governance capable of stewarding it well, New Zealand will give itself a better chance of turning its ideas into companies, jobs and long-term national wealth.

Author bio

Scott Weenink is a New Zealand based investor, company director and former corporate finance lawyer. He is Chair of Xceda Capital Group and Punakaiki Fund, and a founding shareholder and former Chair of Generate KiwiSaver, with experience across finance, governance, technology, sport and international business.